Aurobindo Pharma incorporates wholly owned subsidiary

25 Feb 2026 Evaluate

Aurobindo Pharma has incorporated a new wholly owned subsidiary in the name of Engenra Biologics, on February 24, 2026. The object of incorporation of this wholly owned subsidiary is to expand the contract manufacturing and other pharmaceutical manufacturing operations.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1271.55 -7.75 (-0.61%)
24-Mar-2026 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.90
Dr. Reddys Lab 1262.25
Cipla 1233.70
Zydus Lifesciences 881.10
Lupin 2330.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×